Nine drugmakers cut deal with Trump administration to slash medication costs

Pharmaceutical companies have raised the prices of numerous brand-name drugs this January, despite previous agreements made with the Trump administration aimed at controlling medication costs. This price increase highlights a disconnect between negotiated deals and actual market practices, raising concerns for consumers and healthcare providers alike.

The Trump administration has sent out hundreds of letters terminating federal grants that support mental health and drug addiction services, with potential cuts amounting to $2 billion. This decision has raised significant concerns among advocates and service providers who fear the impact on vulnerable populations relying on these essential services.

RFK Jr. has introduced new U.S. dietary guidelines as part of the Trump administration’s “Make America Healthy Again” campaign, reshaping the national food pyramid and encouraging Americans to alter their eating habits to focus on animal protein and full-fat dairy. Expert insights from registered nutritionist Charlotte DEBEUGNY in Paris are included to assess the implications of these changes.

A federal judge has mandated the Trump administration to reinstate nearly $12 million in funding to the American Academy of Pediatrics, which is crucial for children's health programs. This decision comes amid ongoing litigation involving the Department of Health and Human Services (HHS) and the Academy, which has been critical of recent funding cuts.